Editorial
Lung Cancer and Microbiome
Cancer de pulmon y microbioma
a Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain
b Spanish National Cancer Research Center (CNIO), Madrid, Spain
c Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Madrid, Spain
d Universidad Complutense de Madrid (UCM), Madrid, Spain
e Hospital Universitario 12 de Octubre, Madrid, Spain
Read
2828
Timeswas read the article
923
Total PDF
1905
Total HTML
Share statistics
array:24 [ "pii" => "S0300289619302406" "issn" => "03002896" "doi" => "10.1016/j.arbres.2019.04.012" "estado" => "S300" "fechaPublicacion" => "2020-01-01" "aid" => "2166" "copyrightAnyo" => "2019" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Arch Bronconeumol. 2020;56:3-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 156 "formatos" => array:2 [ "HTML" => 99 "PDF" => 57 ] ] "Traduccion" => array:1 [ "en" => array:18 [ "pii" => "S1579212919304264" "issn" => "15792129" "doi" => "10.1016/j.arbr.2019.04.018" "estado" => "S300" "fechaPublicacion" => "2020-01-01" "aid" => "2166" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Arch Bronconeumol. 2020;56:3-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1 "HTML" => 1 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Lung Cancer and Microbiome" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "3" "paginaFinal" => "4" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Cancer de pulmon y microbioma" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Eva María Garrido-Martín, Luis Paz-Ares" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Eva María" "apellidos" => "Garrido-Martín" ] 1 => array:2 [ "nombre" => "Luis" "apellidos" => "Paz-Ares" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0300289619302406" "doi" => "10.1016/j.arbres.2019.04.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619302406?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212919304264?idApp=UINPBA00003Z" "url" => "/15792129/0000005600000001/v3_202001222229/S1579212919304264/v3_202001222229/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S0300289619302455" "issn" => "03002896" "doi" => "10.1016/j.arbres.2019.04.017" "estado" => "S300" "fechaPublicacion" => "2020-01-01" "aid" => "2171" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Arch Bronconeumol. 2020;56:5-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 222 "formatos" => array:2 [ "HTML" => 153 "PDF" => 69 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Mirar el bosque y no el árbol: el microbioma en la enfermedad pulmonar obstructiva crónica y la fibrosis quística" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "5" "paginaFinal" => "6" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Look at the wood and not at the tree: The Microbiome in Chronic Obstructive Lung Disease and Cystic Fibrosis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Eduard Monsó" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Eduard" "apellidos" => "Monsó" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212919303520" "doi" => "10.1016/j.arbr.2019.04.014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212919303520?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619302455?idApp=UINPBA00003Z" "url" => "/03002896/0000005600000001/v5_202003060711/S0300289619302455/v5_202003060711/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0300289619300274" "issn" => "03002896" "doi" => "10.1016/j.arbres.2019.01.016" "estado" => "S300" "fechaPublicacion" => "2020-01-01" "aid" => "2081" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Arch Bronconeumol. 2020;56:1-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 397 "formatos" => array:2 [ "HTML" => 308 "PDF" => 89 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Microbioma y asma" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1" "paginaFinal" => "2" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The Microbiome and Asthma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Luis García-Rivero" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Juan Luis" "apellidos" => "García-Rivero" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212919303490" "doi" => "10.1016/j.arbr.2019.01.025" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212919303490?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619300274?idApp=UINPBA00003Z" "url" => "/03002896/0000005600000001/v5_202003060711/S0300289619300274/v5_202003060711/es/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S0300289620300521" "issn" => "03002896" "doi" => "10.1016/j.arbres.2020.01.020" "estado" => "S300" "fechaPublicacion" => "2020-06-01" "aid" => "2413" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2020;56:410" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Microbioma de la vía aérea inferior y cáncer de pulmón" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "410" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The Lower Airway Microbiome and Lung Cancer" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Eduardo García-Pachón, Isabel Padilla-Navas" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Eduardo" "apellidos" => "García-Pachón" ] 1 => array:2 [ "nombre" => "Isabel" "apellidos" => "Padilla-Navas" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212920300963" "doi" => "10.1016/j.arbr.2020.01.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212920300963?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289620300521?idApp=UINPBA00003Z" "url" => "/03002896/0000005600000006/v3_202010110737/S0300289620300521/v3_202010110737/es/main.assets" ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Lung Cancer and Microbiome" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "3" "paginaFinal" => "4" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Eva María Garrido-Martín, Luis Paz-Ares" "autores" => array:2 [ 0 => array:3 [ "nombre" => "Eva María" "apellidos" => "Garrido-Martín" "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 1 => array:4 [ "nombre" => "Luis" "apellidos" => "Paz-Ares" "email" => array:1 [ 0 => "emgarrido@ext.cnio.es" ] "referencia" => array:6 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] 4 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] 5 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:5 [ 0 => array:3 [ "entidad" => "Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Spanish National Cancer Research Center (CNIO), Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Madrid, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Universidad Complutense de Madrid (UCM), Madrid, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Hospital Universitario 12 de Octubre, Madrid, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Cancer de pulmon y microbioma" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The human microbiome comprises the collective genomes of all bacteria, archaea, eukaryotic viruses, bacteriophages, fungi and protozoa that colonize the body, acquired through vertical transmission and exposure to the environment.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">1</span></a> The principal niches of microorganisms in the human body include the gastrointestinal tract, the oral cavity, the urogenital tract, the skin, and the upper and lower respiratory tracts. This complex ecosystem benefits the host by bioconverting nutrients and protecting against pathogenic microbes. Its imbalance, or dysbiosis, can ultimately lead to disease.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The microbiome has important immunomodulatory properties, conferring benefits or disease susceptibility to the body. The intestinal microbiota shapes the innate and adaptive immune responses against inflammation, infections, and favours commensal tolerance.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">2</span></a> It is known that the imbalance of the human microbiome or dysbiosis occurs in systemic diseases such as diabetes and chronic gastrointestinal diseases. And there are numerous evidences of its vital role in carcinogenesis, due to direct oncogenic effects, generation of trophic factors, and metabolic, inflammatory and immunomodulatory changes. The alteration of the microbiota by the chronic use of certain antibiotics has been associated with an increased risk of cancer development.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">3</span></a> The impact of the intestinal microbiome has been widely demonstrated in the case of digestive cancer, as the transfer of wild-mice gut microbiota into C57BL/6 laboratory mice protects them from viral infection and gastrointestinal cancer.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">4</span></a> In lung cancer, recent studies have shown that local microbiota dysbiosis and inflammation also correlates with cancer development via T-cells.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">5</span></a> Searching for specific biomarkers, a study of the microbiome in bronchoalveolar lavage fluid identified <span class="elsevierStyleItalic">Veillonella</span> and <span class="elsevierStyleItalic">Megasphaera</span> as more abundant in lung cancer than in benign lesions.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">6</span></a> A meta-analysis of epidemiologic studies analyzed previous lung infections as risk factors for lung cancer. The relationship between infection by <span class="elsevierStyleItalic">Chlamydia pneumoniae</span> or <span class="elsevierStyleItalic">Mycobacterium</span><span class="elsevierStyleItalic">tuberculosis</span> and an increased risk of lung cancer was studied (in 22 and 30 published studies, respectively). The results showed that a previous infection with either microorganism associated with an increased risk of lung cancer.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">7</span></a> There are also microorganisms that confer protection against lung cancer, as <span class="elsevierStyleItalic">Lactobacillus</span>, that seems to have a therapeutic effect in a lung cancer mouse model.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">8</span></a> Regarding the mechanism for dysbiosis, it seems that many byproducts of the host inflammation are growth factors for <span class="elsevierStyleItalic">Gamma proteobacteria</span>. These bacteria create a chronic inflammatory environment that promotes proliferation and survival of malignant cells, aberrant angiogenesis, and tumour metastasis. However, the deleterious effect that pathogenic microbiota exerts in the organism can be counteracted. A study investigated the role of the microbiome existing in the host in the carcinogenesis of lung cancer, using mice. For the study, a group of mice was subjected to urethane-induced lung adenocarcinoma, and was later administered with prebiotics by oral gavage, compared to control group. The result of the study revealed that the presence of <span class="elsevierStyleItalic">Clostridiales</span> and <span class="elsevierStyleItalic">Lachnospiraceae</span> families was lower in both lung and intestinal tracts in mice with induced lung adenocarcinoma, and that <span class="elsevierStyleItalic">S24-7</span>, <span class="elsevierStyleItalic">Bacteroidales</span> and <span class="elsevierStyleItalic">Firmicutes</span> were more abundant in their intestinal tract. All of them returned to normal levels after prebiotics administration, indicating a possible therapeutic approach.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">9</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Not only the microbiome has a role in the generation and progression of cancer, but it can also influence the response to chemotherapies and immunotherapies. Therefore, the microbiome manipulation in anticancer therapies has been explored under different perspectives. On the one hand, by direct modulation of the carcinogenic potential of the microbiome, either blocking the production of oncogenic bacterial products or inhibiting the production of bacterial enzymes that convert anticancer drugs into toxic products.<a class="elsevierStyleCrossRefs" href="#bib0125"><span class="elsevierStyleSup">10,11</span></a> A rational modulation of the microbiota with specific antibiotics could therefore have a positive effect in certain oncologic therapies.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">3</span></a> On the other hand, several studies demonstrate a diminished effect of certain anti tumour chemotherapies and immunotherapies in germ-free mice, as well as in mice treated with wide-spectrum antibiotics. The modification of the microbiota by the use of certain antibiotics has been associated with a reduction in the clinical benefit of therapies with immune checkpoint inhibitors -such as PD-L1 and CTLA4 blockade- in Non-Small-Cell Lung Cancer (NSCLC).<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">3,12</span></a> The fact that specific intestinal commensal bacteria boost the antitumoral responses of the host even in distal locations of the organism lays the foundation of their role in the efficacy of cancer immunotherapies.<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">3,13</span></a> In NSCLC, the efficacy of CTLA-4 blockade was associated with T-cell responses specific for <span class="elsevierStyleItalic">Bacteroides fragilis</span> or <span class="elsevierStyleItalic">Bacteroides thetaiotaomicron</span>.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">14</span></a> Regarding PD-1/PD-L1 blockade therapy, an important study suggested that patients with NSCLC can be stratified into responders and non-responders, based on the composition of their gut microbiota. This study analysed the faecal microbiota of 153 patients with NSCLC, finding more bacteria from <span class="elsevierStyleItalic">Akkermansia</span><span class="elsevierStyleItalic">muciniphila</span> in the anti-PD-L1 responders.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">15</span></a> The tumours from mice that received a Faecal Microbial Transplantation (FMT) from responders showed a higher density of antitumour CD8<span class="elsevierStyleSup">+</span> T-cells, while tumours of mice that received transplant from non-responders showed more immunosuppressive CD4<span class="elsevierStyleSup">+</span> T-reg cells.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Therefore, the manipulation of the microbiota seems to be a promising strategy to develop novel therapeutic approaches in both prevention and treatment of lung cancer. The most important characteristic observed in responders to immunotherapy is their ratio of favourable/not-favourable bacteria.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">13</span></a> It is not clear if a positive response can be caused by a single microorganism or even by a combination. Most likely would be influenced by the interaction of several species with the host, involving complex ecological and metabolic changes, that ultimately affect cancer immunity. The mechanism by which favourable bacteria help the efficacy of immunotherapy seems to be that they support the priming of the T-cells against tumour antigens. In order to improve this equation by increasing favourable bacteria, different strategies can be used: (i) FMT using as donor a patient that has previously responded to therapy anti-PD-1. (ii) The administration of probiotics as dietary supplements. Not only introducing traditional beneficial bacteria such as Bifidobacterium and lactic acid-producing bacteria, but also next-generation beneficial bacteria such as <span class="elsevierStyleItalic">A.</span><span class="elsevierStyleItalic">muciniphila</span>, that have been introduced in preclinical trials with success.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">15</span></a></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:15 [ 0 => array:3 [ "identificador" => "bib0080" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Accounting for reciprocal host–microbiome interactions in experimental science" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "T.S. Stappenbeck" 1 => "H.W. Virgin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nature18285" "Revista" => array:6 [ "tituloSerie" => "Nature" "fecha" => "2016" "volumen" => "534" "paginaInicial" => "191" "paginaFinal" => "199" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27279212" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0085" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Compartmentalized and systemic control of tissue immunity by commensals" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Y. Belkaid" 1 => "S. Naik" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ni.2604" "Revista" => array:6 [ "tituloSerie" => "Nat Immunol" "fecha" => "2013" "volumen" => "14" "paginaInicial" => "646" "paginaFinal" => "653" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23778791" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0090" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticancer effects of the microbiome and its products" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "L. Zitvogel" 1 => "R. Daillère" 2 => "M.P. Roberti" 3 => "B. Routy" 4 => "G. Kroemer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nrmicro.2017.44" "Revista" => array:6 [ "tituloSerie" => "Nat Rev Microbiol" "fecha" => "2017" "volumen" => "15" "paginaInicial" => "465" "paginaFinal" => "478" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28529325" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0095" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Wild mouse gut microbiota promotes host fitness and improves disease resistance" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.P. Rosshart" 1 => "B.G. Vassallo" 2 => "D. Angeletti" 3 => "D.S. Hutchinson" 4 => "A.P. Morgan" 5 => "K. Takeda" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cell.2017.09.016" "Revista" => array:6 [ "tituloSerie" => "Cell" "fecha" => "2017" "volumen" => "171" "paginaInicial" => "1015" "paginaFinal" => "1028" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29056339" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0100" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Commensal microbiota promote lung cancer development via γδ T cells" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "C. Jin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Cell" "fecha" => "2019" "volumen" => "176" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0105" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "S.H. Lee" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.lungcan.2016.10.016" "Revista" => array:6 [ "tituloSerie" => "Lung Cancer" "fecha" => "2016" "volumen" => "102" "paginaInicial" => "89" "paginaFinal" => "95" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27987594" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0110" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Previous lung diseases and lung cancer risk: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.R. Brenner" 1 => "J.R. McLaughlin" 2 => "R.J. Hung" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0017479" "Revista" => array:5 [ "tituloSerie" => "PLoS ONE" "fecha" => "2011" "volumen" => "6" "paginaInicial" => "e17479" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21483846" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0115" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Q.F. Gui" 1 => "H.F. Lu" 2 => "C.X. Zhang" 3 => "Z.R. Xu" 4 => "Y.H. Yang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4238/2015.May.25.16" "Revista" => array:6 [ "tituloSerie" => "Genet Mol Res" "fecha" => "2015" "volumen" => "14" "paginaInicial" => "5642" "paginaFinal" => "5651" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26125762" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0120" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The association between inflammation, the microbiome and urethane-induced pulmonary adenocarcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "Z. Deng" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3892/ol.2018.8167" "Revista" => array:6 [ "tituloSerie" => "Oncol Lett" "fecha" => "2018" "volumen" => "15" "paginaInicial" => "6352" "paginaFinal" => "6360" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29725395" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0125" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "A. Cougnoux" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Gut" "fecha" => "2016" "volumen" => "65" "paginaInicial" => "278" "paginaFinal" => "285" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0130" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Structure and inhibition of microbiome β-glucuronidases essential to the alleviation of cancer drug toxicity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "B.D. Wallace" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.chembiol.2015.08.005" "Revista" => array:6 [ "tituloSerie" => "Chem Biol" "fecha" => "2015" "volumen" => "22" "paginaInicial" => "1238" "paginaFinal" => "1249" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26364932" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0135" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "L. Derosa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/annonc/mdy103" "Revista" => array:6 [ "tituloSerie" => "Ann Oncol" "fecha" => "2018" "volumen" => "29" "paginaInicial" => "1437" "paginaFinal" => "1444" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29617710" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0140" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "L. Zitvogel" 1 => "Y. Ma" 2 => "D. Raoult" 3 => "G. Kroemer" 4 => "T.F. Gajewski" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.aar6918" "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "2018" "volumen" => "359" "paginaInicial" => "1366" "paginaFinal" => "1370" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29567708" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0145" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M. Vétizou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.aad1329" "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "2015" "volumen" => "350" "paginaInicial" => "1079" "paginaFinal" => "1084" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26541610" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0150" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "B. Routy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.aan3706" "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "2018" "volumen" => "359" "paginaInicial" => "91" "paginaFinal" => "97" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29097494" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/03002896/0000005600000001/v5_202003060711/S0300289619302406/v5_202003060711/en/main.assets" "Apartado" => array:4 [ "identificador" => "14517" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Editorials / Editoriales" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005600000001/v5_202003060711/S0300289619302406/v5_202003060711/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619302406?idApp=UINPBA00003Z" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 4 | 4 | 8 |
| 2024 October | 57 | 23 | 80 |
| 2024 September | 60 | 15 | 75 |
| 2024 August | 113 | 36 | 149 |
| 2024 July | 46 | 15 | 61 |
| 2024 June | 59 | 19 | 78 |
| 2024 May | 82 | 29 | 111 |
| 2024 April | 59 | 29 | 88 |
| 2024 March | 49 | 19 | 68 |
| 2024 February | 39 | 24 | 63 |
| 2024 January | 1 | 0 | 1 |
| 2023 May | 1 | 0 | 1 |
| 2023 March | 15 | 5 | 20 |
| 2023 February | 79 | 20 | 99 |
| 2023 January | 61 | 31 | 92 |
| 2022 December | 90 | 27 | 117 |
| 2022 November | 95 | 33 | 128 |
| 2022 October | 99 | 49 | 148 |
| 2022 September | 60 | 78 | 138 |
| 2022 August | 74 | 62 | 136 |
| 2022 July | 56 | 45 | 101 |
| 2022 June | 61 | 56 | 117 |
| 2022 May | 64 | 41 | 105 |
| 2022 April | 108 | 41 | 149 |
| 2022 March | 115 | 69 | 184 |
| 2022 February | 126 | 45 | 171 |
| 2022 January | 111 | 36 | 147 |
| 2021 May | 2 | 0 | 2 |
| 2021 February | 1 | 2 | 3 |
| 2020 December | 1 | 0 | 1 |
| 2020 October | 0 | 2 | 2 |
| 2020 September | 1 | 0 | 1 |
| 2020 July | 3 | 0 | 3 |
| 2020 June | 2 | 0 | 2 |
| 2020 May | 4 | 0 | 4 |
| 2020 April | 3 | 4 | 7 |
| 2020 March | 3 | 3 | 6 |
| 2020 February | 21 | 8 | 29 |
| 2020 January | 77 | 45 | 122 |
| 2019 December | 3 | 8 | 11 |
Show all
